Direct-to-consumer prescription drug advertising and the public
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
OBJECTIVE: Drug manufacturers are intensely promoting their products directly to consumers, but the impact has not been widely studied. Consumers’ awareness and understanding of, attitudes toward, and susceptibility to direct-to-consumer (DTC) drug advertising were examined.
DESIGN: Random-digit dialing telephone survey with a random household member selection procedure (completion and response rates, 58% and 69%, respectively).
SETTING: Respondents were interviewed while they were at their residences.
PARTICIPANTS: Complete data were obtained from 329 adults in Sacramento County, California.
MEASUREMENTS AND MAIN RESULTS: Outcome measures included awareness of advertisements for 10 selected drugs, misconceptions about DTC advertising, attitudes toward DTC ads, and behavioral responses to such promotions. The influence of demographic characteristics, health status, attitudes, beliefs, and media exposure on awareness and behaviors was examined. On average, respondents were aware of advertisements for 3.7 of the 10 drugs; awareness varied from 8% for Buspar (buspirone) to 72% for Claritin (loratadine). Awareness was associated with prescription drug use, media exposure, positive attitudes toward DTC advertising, poorer health, and insurance status. Substantial misconceptions were revealed; e.g., 43% thought that only “completely safe” drugs could be advertised. Direct-to-consumer advertisements had led one third of respondents to ask their physicians for drug information and one fifth to request a prescription.
CONCLUSIONS: Direct-to-consumer advertisements are reaching the public, but selectively so, and affecting their behaviors. Implications for public policy are examined.
- Mueller C, Schur C, O’Connell J. Prescription drug spending: the impact of age and chronic disease status. Am J Public Health. 1997;87:1626–9.
- Giaquinta D. Drug formularies—good or evil? A view from a managed care provider. Cardiology. 1994;85(suppl 1):30–5.
- Jaklevic MC. Prescribed cutback: HMOs shift risk to doc groups to curb drug utilization. Mod Healthcare. 1997;27(29):34.
- Growth seen in ads for direct-to-consumer drugs. Am Med News. April 27, 1998:16.
- ’t Hoen E. Direct-to-consumer advertising: for better profits or for better health? Am J Health-System Pharmacy. 1998;55:594–7.
- Alperstein NM, Peyrot M. Consumer awareness of prescription drug advertising. J Advertising Res. 1993;33(4):50–6.
- Rogers EM. Diffusion of Innovations. 3rd ed. New York, NY: The Free Press; 1983:241–70.
- Bradley L, Zito JM. Direct-to-consumer prescription drug advertising. Med Care. 1997;35:86–92. CrossRef
- Waksberg J. Sampling methods for random digit dialing. J Am Stat Assoc. 1978;73:40–6. CrossRef
- Hagen DE, Collier CM. Must respondent selection procedures for telephone surveys be invasive? Public Opin Q. 1983;47:547–56. CrossRef
- Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika. 1951;16:297–334. CrossRef
- Carmines EG, Zeller RA. Reliability and Validity Assessment. Newbury Park, Calif: Sage; 1979.
- Ware JE Jr. SF-36 Health Survey: Manual And Interpretation. Boston, Mass: The Health Institute, New England Medical Center; 1993.
- Bentler PM, Wu EJC. EQS for Windows Users Guide. Encino, Calif: Multivariate Software, Inc.; 1995.
- Hosmer DW, Lemeshow S. Applied Logistic Regression. New York, NY: John Wiley; 1989.
- Everett SE. Lay audience response to prescription drug advertising. J Advertising Res. 1991;31(2):43–9.
- Nordenberg T. Direct to you: TV drug ads that make sense. FDA Consumer. 1998;32:7.
- O’Keefe DJ. Persuasion: Theory and Research. Newbury Park, Calif: Sage; 1990.
- Morris LA, Brinberg D, Klimberg R, Rivera C, Millstein LG. Miscomprehension rates for prescription drug advertisements. Curr Issues Res Advertising. 1986;9(1,2):93–117.
- Morris LA, Brinberg D, Klimberg R, Millstein L, Rivera C. Consumer attitudes about advertisements for medicinal drugs. Soc Sci Med. 1986;22:629–38. CrossRef
- Percy L, Rossiter JR. A model of brand awareness and brand attitude advertising strategies. Psychol Marketing. 1992;9:263–74. CrossRef
- Sitthi-Amorn C, Ngamvithayapongse J. The role of media and communication in improving the use of drugs and other technologies. Int J Technol Assess Health Care. 1998;14:71–80. CrossRef
- Wilkes MS, Doblin BH, Shapiro MF. Pharmaceutical advertisements in leading medical journals: Experts’ assessments. Ann Intern Med. 1992;116:912–9.
- Lexchin J. What information do physicians receive from pharmaceutical representatives? Can Fam Physician. 1997;43:941–5.
- Vener AM, Krupka LR. Over-the-counter drug advertising in gender oriented popular magazines. J Drug Educ. 1986;16:367–81.
- Direct-to-consumer prescription drug advertising and the public
Journal of General Internal Medicine
Volume 14, Issue 11 , pp 651-657
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- prescription drugs
- drug safety
- drug promotion
- drug regulation
- Industry Sectors
- Author Affiliations
- 1. Department of Communication, University of California, 95616, Davis, CA
- 2. Division of General Internal Medicine and Director, Center for Health Services Research in Primary Care, University of California, Davis, Sacramento, Calif
- 3. Department of Medicine, School of Medicine, University of California, Los Angeles, Los Angeles, Calif